L. C. Pati, D. Mukherjee / Tetrahedron Letters 45 (2004) 9451–9453
9453
7. Matsumoto, T.;Endo, Y.;Okimoto, M. Bull. Chem. Soc.
Jpn. 1983, 56, 2018–2022.
8. Tamai, Y.;Hagiwara, H.;Uda, H. J. Chem. Soc., Perkin
Trans. 1 1986, 1311–1315.
9. Banerjee, A. K.;Hurtado, S. H.;Laya, M. M.;Acevedo, J.
C.;Alvarej, G. J. J. Chem. Soc., Perkin Trans. 1 1988,
931–938.
10. Kametani, T.;Kondoh, H.;Tsubuki, M.;Honda, T.
Chem. Soc., Perkin Trans. 1 1990, 5–10.
J.
11. Bush, E. J.;Jones, D. W. J. Chem. Soc., Perkin Trans. 1
1997, 3531–3536.
12. Bhattacharyya, S.;Ghosal, M.;Mukherjee, D. Tetrahe-
dron Lett. 1987, 28, 2431–2432.
13. Ye, T.;McKervey, M. A. Chem. Rev. 1994, 94, 1091–1160,
and references cited therein.
Figure 3. Single crystal X-ray structure of synthetic pisiferal 2 (an
ORTEP drawing).
14. Huffman, J. W.;Arapakos, P. G. J. Org. Chem. 1965, 30,
1604–1607.
15. Satisfactory spectroscopic and microanalytical data were
obtained for all new compounds.
hydrogenation in the presence of a catalytic amount of
HClO4 furnished the acetate 2216 (78%). Fujita and
co-workers reported17 that a combination of aluminium
halide and ethanethiol is very effective for demethylation
of methyl ethers of phenols whilst acetoxy groups are
stable to this reagent system. Demethylation of 22 with
anhydrous AlCl3 and EtSH afforded the phenol 23
(75%) which on reduction with LiAlH4 furnished ( )-
pisiferol (1)16 in 87% yield. The phenol 23 exhibits signi-
ficant antitumour activity and inhibits5 the growth of
human cervix uteri HeLa cells. Treatment of 1 with
Jones’ reagent at 0ꢁC for a brief period provided
( )-pisiferal (2)16 (48%). The identity of synthetic 2
was secured through single crystal X-ray crystallogra-
phy (Fig. 3). Also, the spectral data of 1 and 2 agreed
very well with those reported in the literature.
16. Selected spectral data for the enedione 16: 1H NMR
(CDCl3, 300MHz): d 1.29 (s, 3H), 1.37 (s, 3H), 2.34, 2.54
(ABq, 2H, J = 15.7Hz), 2.34, 3.80 (ABq, 2H, J = 18Hz),
3.63 (s, 3H), 3.88 (s, 3H), 6.71 (s, 1H), 6.94 (d, 1H,
J = 2.4Hz), 7.02 (dd, 1H, J = 8.7, 2.4Hz), 8.17 (d, 1H,
J = 8.7Hz); 13C NMR (CDCl3, 75MHz): d 30.5, 32.2,
38.1, 46.5, 51.7, 51.8, 53.6, 55.6, 110.3, 114.9, 123.7, 127.7,
129.1, 143.1, 162.4, 163.5, 171.8, 183.5, 206.2. For the ester
1
19: H NMR (CDCl3, 300MHz): d 0.77 (s, 3H), 0.96 (s,
3H), 1.18–1.31 (m, 2H), 1.43–1.52 (m, 2H), 1.58–1.66 (m,
1H), 1.87–2.05 (m, 2H), 2.37–2.55 (m, 1H), 2.80–2.96 (m,
3H), 3.54 (s, 3H), 3.73 (s, 3H), 6.69 (dd, 1H, J = 8.4,
2.6Hz), 6.84 (d, 1H, J = 2.6Hz), 7.00 (d, 1H, J = 8.4Hz);
13C NMR (CDCl3, 75MHz): d 18.6, 20.0, 20.3, 29.2, 32.0,
33.9, 37.0, 41.7, 48.0, 51.5, 52.2, 55.1, 110.9, 112.4, 129.0,
1
130.3, 141.5, 157.4, 175.7. For the methyl ketone 21: H
In conclusion, a stereocontrolled synthesis of the abi-
etane-type tricyclic diterpenes ( )-pisiferol and ( )-pisi-
feral has been accomplished involving aryl participated
intramolecular cyclisation of an appropriately substi-
tuted diazomethyl ketone as a key reaction.
NMR (CDCl3, 300MHz): d 0.98 (s, 6H), 1.25–1.84 (m,
8H), 1.93 (s, 3H), 2.54–2.60 (m, 1H), 2.59 (s, 3H), 2.81–
3.00 (m, 2H), 3.88 (s, 3H), 4.16, 4.54 (ABq, 2H, J = 11Hz),
6.88 (s, 1H), 7.46 (s, 1H); 13C NMR (CDCl3, 75MHz): d
18.2, 18.7, 20.9, 22.2, 28.1, 31.7, 33.1, 33.4, 33.5, 41.1, 41.2,
50.0, 55.4, 65.5, 109.9, 126.0, 128.1, 130.7, 150.1, 156.0,
170.5, 199.4. For the acetate 22: 1H NMR (CDCl3,
300MHz): d 0.96 (s, 6H), 1.18 and 1.19 (2 d, 2 · 3H,
J = 7.0Hz each), 1.24–1.93 (m, 8H), 1.92 (s, 3H), 2.53–2.57
(m, 1H), 2.83–2.94 (m, 2H), 3.22 (sept, 1H, J = 7.0Hz),
3.79 (s, 3H), 4.14, 4.55 (ABq, 2H, J = 10.8Hz), 6.76 (s,
1H), 6.86 (s, 1H); 13C NMR (CDCl3, 75MHz): d 18.6,
18.9, 21.0, 22.3, 22.6, 22.8, 26.4, 28.8, 33.3, 33.4, 33.6, 40.5,
41.5, 50.5, 55.5, 66.1, 109.2, 126.4, 127.5, 134.9, 142.0,
154.0, 170.8. For pisiferol 1: 1H NMR (CDCl3, 300MHz):
d 0.90 (s, 3H), 0.94 (s, 3H), 1.22 (d, 6H, J = 6.9Hz), 1.14–
1.90 (m, 8H), 2.46–2.50 (m, 1H), 2.80–2.96 (m, 2H), 3.19
(sept, 1H, J = 6.9Hz), 3.62, 3.99 (ABq, 2H, J = 11Hz),
6.65 (s, 1H), 6.90 (s, 1H); 13C NMR (CDCl3, 75MHz): d
18.4, 18.8, 22.3, 22.5, 22.7, 26.7, 28.7, 32.7, 33.2, 33.4, 41.6,
42.3, 50.1, 63.8, 112.8, 127.4, 127.7, 133.0, 141.3, 150.8.
For pisiferal 2: 1H NMR (CDCl3, 300MHz): d 0.82 (s,
3H), 1.00 (s, 3H), 1.22 (d, 6H, J = 6.9Hz), 1.13–1.72 (m,
6H),2.00–2.14 (m, 2H), 2.83–2.99 (m, 3H), 3.14 (sept, 1H,
J = 6.9Hz), 4.83 (br s, 1H), 6.56 (s, 1H), 6.92 (s, 1H), 9.89
(d, 1H, J = 1.2Hz); 13C NMR (CDCl3, 75MHz): d 18.3,
19.6, 20.6, 22.4, 22.5, 26.9, 30.1, 31.5, 32.6, 33.9, 41.3, 51.7,
53.1, 113.8, 127.2, 130.4, 133.4, 134.2, 151.6, 200.9.
17. Node, M.;Nishide, K.;Fuji, K.;Fujita, E. J. Org. Chem.
1980, 45, 4275–4277.
Acknowledgements
We are grateful to the CSIR, New Delhi, for financial
support (Grant No 01(1742)/02/EMR-II). One of us
(L.C.P.) thanks the CSIR for a fellowship.
References and notes
1. Yatagai, M.;Takahashi, T. Phytochemistry 1980, 19,
1149–1151.
2. Yatagai, M.;Takahashi, T. Phytochemistry 1979, 18, 176,
and references cited therein.
3. Kobayashi, K.;Nishino, C.;Tomita, H.;Fukushima, M.
Phytochemistry 1987, 26, 3175–3179.
4. Yatagai, M.;Nakatani, N. Mokuzai Gakkaishi 1994, 40,
1355–1362, Chem. Abstr. 1995, 122, 154117t.
5. Nishino, C.;Kobayashi, K.;Sato, S.;Oya, J. Japanese
Patent No JP 61271216 A2 19861201 Showa; Chem. Abstr.
1987, 106, 214163m.
6. Matsumoto, T.;Usui, S. Bull. Chem. Soc. Jpn. 1982, 55,
1599–1604.